Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...

Novo Nordisk is ramping up its manufacturing sites ... which has been approved for use to treat obesity in Britain, Denmark, France, Germany, Norway and the United States, rose by 42 percent ...

As the "Trump trade" heated up, coupled with market anticipation that the Fed will cut interest rates by another quarter point this week, the three major US stock index futures widened their gains ...

Novo Nordisk landed in hot water with the FDA following an inspection at one of the drugmaker’s key semaglutide and insulin manufacturing plants this past spring. | The FDA issued a ...

Danish pharmaceutical giant Novo Nordisk sees a significant increase in profits and sales despite production constraints.

Biocon is the first company to win U.K. authorization to offer a generic version of Novo Nordisk’s Saxenda weight ... these drugs at the right price.” France’s Economy Minister Antoine ...